Skip to main content
Top
Published in: Infection 1/2015

Open Access 01-02-2015 | Case Report

Severe Staphylococcus lugdunensis keratitis

Authors: N. Inada, N. Harada, M. Nakashima, J. Shoji

Published in: Infection | Issue 1/2015

Login to get access

Abstract

We report a severe case of Staphylococcus lugdunensis (S. lugdunensis) keratitis presenting as suppurative keratitis in a 77-year-old woman. The patient’s chief complaint was eye pain and decreased visual acuity in her right eye. Suppurative keratitis with a severe corneal abscess was diagnosed by a slit-lamp ophthalmic examination. The causative organism was identified as S. lugdunensis by bacterial culture, using a corneal abrasion specimen. She was treated with an intravenous drip infusion of ceftazidime and instillation of gentamicin sulfate ophthalmic solution (six times daily) and ofloxacin ophthalmic ointment (once daily before bedtime) as empiric therapy. Her hospital course was complicated by a corneal perforation of her right eye. The antibiotic susceptibility for S. lugdunensis was sensitive, but with a slightly high MIC for antibiotics used in empiric therapy. The therapeutic drug was changed to levofloxacin ophthalmic solution. The corneal abscess left a scar after healing. Representative causative organisms of suppurative keratitis include Pseudomonas aeruginosa and Streptococcus pneumoniae, but care must be taken in cases involving rare causative organisms. Empiric therapy is necessary for rapidly progressing suppurative keratitis, but a detailed examination of the causative organism is important for therapeutic planning before empiric therapy.
Literature
1.
go back to reference Pandita A, Murphy C. Microbial keratitis in Waikato,New Zealand. Clin Experiment Ophthalmol. 2011;39:393–7.PubMedCrossRef Pandita A, Murphy C. Microbial keratitis in Waikato,New Zealand. Clin Experiment Ophthalmol. 2011;39:393–7.PubMedCrossRef
2.
go back to reference Lin JF, Cheng CW, Kuo AJ, et al. Clinical experience and microbiologic characteristics of invasive Staphylococcus lugdunensis infection in a tertiary center in northern Taiwan. J Microbiol Immunol Infect. 2014. doi:10.1016/j.jmii.2013.12.010. Lin JF, Cheng CW, Kuo AJ, et al. Clinical experience and microbiologic characteristics of invasive Staphylococcus lugdunensis infection in a tertiary center in northern Taiwan. J Microbiol Immunol Infect. 2014. doi:10.​1016/​j.​jmii.​2013.​12.​010.
3.
go back to reference Papapetropoulos N, Papapetropoulou M, Vantarakis A. Abscesses and wound infection due to Staphylococcus lugdunensis: report of 16 cases. Infection. 2013;41:525–8.PubMedCrossRef Papapetropoulos N, Papapetropoulou M, Vantarakis A. Abscesses and wound infection due to Staphylococcus lugdunensis: report of 16 cases. Infection. 2013;41:525–8.PubMedCrossRef
4.
go back to reference Fujita S, Senda Y, Iwagami T, et al. Rapid identification of Staphylococcal strain from positive-testing blood culture bottles by internal transcribed spacer PCR followed by microchip gel electrophoresis. J Clin Microbiol. 2005;43:1149–57.PubMedCentralPubMedCrossRef Fujita S, Senda Y, Iwagami T, et al. Rapid identification of Staphylococcal strain from positive-testing blood culture bottles by internal transcribed spacer PCR followed by microchip gel electrophoresis. J Clin Microbiol. 2005;43:1149–57.PubMedCentralPubMedCrossRef
5.
go back to reference Kanemitsu K, Kunishima H, Hatta M, et al. Evaluation of a fully automated system (RAISUS) for rapid identification and antimicrobial susceptibility testing of Staphilococci. J Clin Microbiol. 2005;43:5808–10.PubMedCentralPubMedCrossRef Kanemitsu K, Kunishima H, Hatta M, et al. Evaluation of a fully automated system (RAISUS) for rapid identification and antimicrobial susceptibility testing of Staphilococci. J Clin Microbiol. 2005;43:5808–10.PubMedCentralPubMedCrossRef
6.
go back to reference Sueke H, Kaye S, Neal T, et al. Minimum inhibitory concentrations of standard and novel antimicrobials for isolates from bacterial keratitis. Invest Ophthalmol Vis Sci. 2010;51:2519–24.PubMedCrossRef Sueke H, Kaye S, Neal T, et al. Minimum inhibitory concentrations of standard and novel antimicrobials for isolates from bacterial keratitis. Invest Ophthalmol Vis Sci. 2010;51:2519–24.PubMedCrossRef
7.
go back to reference Pinna A, Zanetti S, Sotgiu M, et al. Identification and antibiotic susceptibility of coagulase negative Staphylococci isolated in cornea/external infection. Br J Ophthalmol. 1999;83:771–3.PubMedCentralPubMedCrossRef Pinna A, Zanetti S, Sotgiu M, et al. Identification and antibiotic susceptibility of coagulase negative Staphylococci isolated in cornea/external infection. Br J Ophthalmol. 1999;83:771–3.PubMedCentralPubMedCrossRef
Metadata
Title
Severe Staphylococcus lugdunensis keratitis
Authors
N. Inada
N. Harada
M. Nakashima
J. Shoji
Publication date
01-02-2015
Publisher
Springer Berlin Heidelberg
Published in
Infection / Issue 1/2015
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-014-0669-2

Other articles of this Issue 1/2015

Infection 1/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.